Maraganore headlines Arch’s latest crop of venture partners
Plus Five FDA vets join Sidley and updates from AZ, Neurocrine, ADCendo, Ironwood and more
John Maraganore, the outgoing CEO of Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY), has joined Arch Venture Partners along with Jake Bauer, Axel Bouchon and Sabah Oney. Bauer and Oney both held CBO roles in their most recent posts, Bauer at MyoKardia Inc. and Oney at Alector Inc. (NASDAQ:ALEC). Bouchon, who is co-founder and chairman of BrainLuxury Inc. and co-founder and CEO of BrainGames Corp., previously led venture activities for Leaps by Bayer and Moderna Therapeutics Inc. (NASDAQ:MRNA).
The firm also officially announced the addition of Luciana Borio, a veteran of FDA and the National Security Council who is advising Arch on and helping develop new investment opportunities related to manufacturing, clinical trials, novel therapies and areas with large unmet clinical needs, and the promotion of Carol Suh to partner from principal. The moves related to Borio and Suh became public in July...